The Efficacy of IL-6 Inhibitor Tocilizumab in Reducing Severe COVID-19 Mortality: A Systematic Review

Avi Kaye, Robert Siegel
doi: https://doi.org/10.1101/2020.07.10.20150938

Article usage

Article usage: July 2020 to July 2025

AbstractFullPdf
Jul 202018100368
Aug 20202240108
Sep 20204870123
Oct 20202170121
Nov 2020125060
Dec 2020106035
Jan 202196023
Feb 2021147428
Mar 2021120331
Apr 20211251026
May 20211061236
Jun 202179322
Jul 202156419
Aug 2021551016
Sep 202137322
Oct 202147134
Nov 202160624
Dec 202128319
Jan 202237512
Feb 202230212
Mar 202218318
Apr 202220314
May 202222113
Jun 202227010
Jul 20221808
Aug 202217214
Sep 202233421
Oct 202219122
Nov 20222018
Dec 202226110
Jan 202321211
Feb 202319512
Mar 20237316
Apr 202324212
May 202315121
Jun 202310418
Jul 2023916
Aug 202316138
Sep 20231054
Oct 20231102
Nov 20231766
Dec 202311010
Jan 202415317
Feb 20245016
Mar 2024231220
Apr 202414824
May 202410410
Jun 202410310
Jul 2024328
Aug 20242188
Sep 202419112
Oct 2024957
Nov 202416115
Dec 202416129
Jan 202511520
Feb 2025142912
Mar 2025305421
Apr 202525526
May 202533919
Jun 2025311413
Jul 2025332
Back to top
Posted September 03, 2020.
Download PDF
Data/Code
Email
The Efficacy of IL-6 Inhibitor Tocilizumab in Reducing Severe COVID-19 Mortality: A Systematic Review
Avi Kaye, Robert Siegel
medRxiv 2020.07.10.20150938; doi: https://doi.org/10.1101/2020.07.10.20150938
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area